Company / Operating Cash Flow
DNA X, Inc. Operating Cash Flow History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$4.1M
FY2024
5-year range
-$38.5M / -$4.1M
FY2020-FY2024
Trend
+67.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 6 years, ranging from -$38M in FY2022 to $4M in FY2019.
Based on SEC 10-K filings.
-$4M in FY2024.
Improved from -$38M to -$4M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow increased 67.2% year-over-year.
- Peak operating cash flow was recorded in FY2019.
- Lowest operating cash flow in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$4.1M | +67.2% |
| FY2023 | -$12.4M | +67.9% |
| FY2022 | -$38.5M | -264.4% |
| FY2021 | -$10.6M | +68.5% |
| FY2020 | -$33.5M | -968.2% |
| FY2019 | $3.9M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026